Galera Therapeutics, Inc. - שווי מצרפי של הפעילות העסקית GRTX

Galera Therapeutics (GRTX) sought to expand the application of small molecules for radiation protection, but all developments have now been nullified due to the complete liquidation of the business. This price chart illustrates the company's valuation dynamics, which currently stand at . The company previously focused on developing agents that activate antioxidants to reduce radiotherapy toxicity, enabling the use of more potent radiation doses.

Against the backdrop of winding down clinical programs and liquidating assets at Galera Therapeutics (GRTX), the actual scale of the business is determined by the sum of its market capitalization and net debt. This formula reflects the total buyout cost of the issuer, while the company's valuation based on the EV metric warns investors of the risks of inflated expectations, where inertial growth on the chart masks a fundamental crisis and threatens long-term losses.